AlenMed

Treatment in Germany

EN

Mon–Fri 9:00–21:00 · Sat 10:00–18:00 (CET)
+49 176 61975550 — daily until 23:00

Haemangioma treatment in Germany

Updated

Most often parents bring a haemangioma to the doctor: a red mark appeared in the baby’s first weeks and grew visibly within a month, and the question is whether to wait or treat. Haemangioma treatment in Germany depends on where the mark is and how fast it grows. In adults the word usually means an incidental finding in the liver or a vertebra on a scan done for another reason.

Below: what a haemangioma is and is not, when to treat and when watching is enough, how German centres investigate and what treatment involves.

What a haemangioma is and what it is not

An infantile haemangioma is a benign vascular tumour that is usually absent at birth. It appears in the first weeks, grows quickly over the first months, then stops growing and slowly shrinks, or involutes, over years.

It is constantly confused with vascular malformations: congenital faults in the vessels that do not disappear on their own and grow with the child. They are treated differently, so the first thing a German doctor does is to tell the two apart; everything else follows from that.

In adults, a liver or vertebral haemangioma is a different story: also a benign vascular lesion, usually symptomless and found by chance, it mostly needs not treatment but a clear report confirming it is a haemangioma. A red mark on adult skin is a reason to see a dermatologist, not to assume it is one; see dermoscopy and skin cancer screening in Germany.

When to treat and when to watch

Treatment is given not because a lesion exists but because it interferes; the rest are watched. That means a haemangioma near the eye blocking vision, on the lip or nose tip, in the airway, ulcerated in the nappy area or large on the face, plus one growing fast in the first weeks, when timing decides.

A separate case is a large segmental haemangioma covering a whole skin area of the face or lower back: it may be part of a syndrome (PHACE or LUMBAR), and then the heart, vessels, eyes and spine are examined. Several skin haemangiomas in an infant call for a liver ultrasound.

Watching is also a decision, not a refusal to help. Small haemangiomas on covered areas resolve on their own in most cases, and the right approach is photographs with a ruler and a booked review, not immediate intervention.

How German centres investigate

Diagnosis rests on examination and Doppler ultrasound, which shows blood flow inside the lesion and helps tell a haemangioma from a malformation. MRI is needed for deep lesions, for the segmental form and when an intervention is planned.

Added when indicated: an ophthalmologist for lesions around the eye, echocardiography and liver ultrasound for multiple lesions, airway assessment if the larynx may be involved. In adults a liver finding is settled by the description on contrast CT or MRI; a biopsy is usually not needed.

What the treatment involves

The first line for an infantile haemangioma that needs treatment is oral propranolol, a beta blocker. Its start is monitored for pulse, blood pressure and blood glucose; then the child is weighed regularly and the dose recalculated. It is also the first choice in the German medical guideline on infantile haemangiomas; its latest version was published in December 2020, its validity ran out in October 2025, and the document is now being revised.

Small superficial lesions are treated with topical timolol gel. Pulsed dye laser is used for ulceration and later for residual dilated vessels, while surgical removal is mainly discussed for residual tissue and excess skin once involution has finished.

What is not done: no treatment just in case, and no promise that no trace will remain, as some children keep skin changes after involution; this is said in advance. A liver haemangioma in an adult is usually just watched; intervention is discussed rarely and on specific grounds.

Who looks after these patients

Children are managed jointly by dermatologists and paediatricians, and German university hospitals run clinics for this with ultrasound, an ophthalmologist and a laser in one place. AlenMed’s partners include the department of dermatology, venereology and allergology at the Charité in Berlin, where Prof. Ulrike Blume-Peytavi is deputy director, the department of dermatology, venereology and allergology at the University Hospital Frankfurt headed by Prof. Bastian Schilling, and the Dr. von Hauner Children’s Hospital of the University Hospital Munich.

The benefit: one appointment can bring the distinction between haemangioma and malformation, the decision on whether treatment is needed and a prescription with a written monitoring schedule, instead of three consultations in three places.

Frequently asked questions

Will a baby’s haemangioma go away on its own?

In most cases it does: after the growth phase it stops and slowly shrinks over several years, though larger ones often leave skin changes such as dilated vessels or excess tissue. Waiting without a plan is unwise: early on, a doctor checks whether it grows too fast or could affect sight, breathing or feeding.

Is propranolol safe for a baby with a haemangioma?

It is a well-studied first-line medicine, made safe by monitoring. Side effects are usually temporary and mild, but blood sugar, heart rate or blood pressure can occasionally drop. So the start is supervised, the medicine is given during or right after a feed, and a dose is skipped if the baby is not eating enough or is vomiting.

Can a haemangioma be removed with a laser?

Laser is not the main method: when a haemangioma needs treatment, the first line is oral propranolol. Pulsed dye laser is used for ulceration and later to fade remaining dilated vessels, while surgery is mainly discussed once involution has finished and excess tissue is left.

How AlenMed arranges the appointment and treatment

AlenMed starts with documents: send in advance photographs of the lesion with a ruler, taken a few weeks apart to show the doctor how it changes, the child’s date of birth and weight, discharge letters and results of investigations already done. A dermatologist makes no decision from a verbal description.

The doctor then says whether the trip is needed and what it will involve; a written estimate, a visa invitation, an appointment date and an interpreter follow. With propranolol, who runs the monitoring at home and on what schedule is agreed in advance. See also dermatology in Germany and treatment of children in Germany.

This material is for information only and is not an offer; the indication for treatment is decided by a doctor in person.